NICE Ltd. (NICE) director exercises stock options, lifting holdings to 4,689 shares

Rhea-AI Filing Summary

NICE Ltd. director Zehava Simon exercised stock options covering 554 Ordinary Shares on 2026-08-13 at an exercise price of $0.3076 per share. The option, which was fully vested and exercisable, was fully converted, leaving 0 options from this grant and resulting in 4,689 Ordinary Shares held directly after the transaction.

Insider Trade Summary

Net Buyer: 554 shares

Net Buy 2 txns

Insider Simon Zehava

Role Director

Type	Security	Shares	Price	Value
Exercise	Options F1	554	$0.00	$0.00
Exercise	Ordinary Shares	554	$0.3076	$170.41

Holdings After Transaction: Options — 0 shares (Direct); Ordinary Shares — 4,689 shares (Direct)

Footnotes (1)

1. F1. The stock option is fully vested and currently exercisable.

Key Figures

Options Exercised: 554 shares Exercise Price: $0.3076 per share Shares Held After: 4,689 Ordinary Shares +2 more

5 metrics

Options Exercised 554 shares Stock options exercised into Ordinary Shares on 2026-08-13

Exercise Price $0.3076 per share Exercise price for the 554 options converted into Ordinary Shares

Shares Held After 4,689 Ordinary Shares Direct holdings of Zehava Simon following the option exercise

Options Remaining from Grant 0 options Total shares following transaction for the reported option grant

Original Option Expiration 2027-04-28 Expiration date of the option before exercise

Key Terms

Exercise or conversion of derivative security, Ordinary Shares, fully vested

3 terms

Exercise or conversion of derivative security financial

"transaction_code_description: Exercise or conversion of derivative security"

Ordinary Shares financial

"underlying_security_title and non-derivative security_title: Ordinary Shares"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

fully vested financial

"footnote: The stock option is fully vested and currently exercisable"

FAQ

What did NICE (NICE) director Zehava Simon report in this Form 4?

Zehava Simon reported exercising stock options for 554 Ordinary Shares of NICE Ltd. at $0.3076 per share, increasing her directly held Ordinary Shares to 4,689 after the transaction.

How many NICE (NICE) options did Zehava Simon exercise and at what price?

She exercised options covering 554 Ordinary Shares at an exercise price of $0.3076 per share. These options were fully vested and currently exercisable at the time of the transaction.

What are Zehava Simon’s NICE (NICE) share holdings after this transaction?

Following the option exercise, Zehava Simon directly holds 4,689 Ordinary Shares of NICE Ltd. The related option grant reported in this filing now has 0 options remaining.

What happened to the NICE (NICE) stock options involved in this Form 4?

The reported stock option, fully vested and exercisable, was exercised for 554 shares and now shows 0 options remaining from this grant, with an original expiration date of 2027-04-28 before exercise.

Was the NICE (NICE) Form 4 transaction by Zehava Simon a market buy or sell?

The filing shows an option exercise converting 554 options into 554 Ordinary Shares, not an open-market purchase or sale. The net effect is increased directly held Ordinary Shares to 4,689.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/14/2026 - 07:01 AM Accepted by SEC EDGAR 08/14/2026 - 07:00 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Simon Zehava

(Last) (First) (Middle)

221 RIVER STREET

(Street)

HOBOKEN NEW JERSEY 07030

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
NICE Ltd. [ NICE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol
[[NICE.TA]]

3. Date of Earliest Transaction (Month/Day/Year)
08/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	08/13/2026		M		554	A	$0.3076	4,689	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options	$0.3076	08/13/2026		M			554	(1)	04/28/2027	Ordinary Shares	554	$0	0	D

Explanation of Responses:

1. The stock option is fully vested and currently exercisable.

	/s/ Alon Levy, Attorney-in-Fact for Zehava Simon	08/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)